Background: Equine atypical myopathy (AM) is a toxic rhabdomyolysis associated with ingestion of hypoglycin A, derived typically in Europe, from Acer pseudoplatanus tree. Despite the wide distribution of this tree species in the UK, the number of cases reported annually varies, and there has been an apparent increase in prevalence in recent years. Although AM was first recognised in the UK, epidemiological studies have never been conducted focused solely on this country. Objectives: To describe the spatiotemporal distribution, presentation, treatment and outcome of AM cases reported in the UK. Study design: Retrospective case series. Methods: British AM cases reported to the atypical myopathy alert website, between 2011 and 2015 were included (n = 224). Data were obtained via standardised epidemiological questionnaires from owners and veterinarians. Factors associated with survival were assessed using logistic regression. Results: Most cases reported were from England (87.9%). Survival was 38.6% (n = 73/189). Clinical factors associated with reduced odds of survival included, hypothermia (odds ratio [OR] 0.18; 95% confidence interval [CI] 0.06-0.57; P = 0.01), bladder distension (OR 0.11; CI 0.02-0.59; P = 0.01), tachycardia (OR 0.97; CI 0.94-0.99; P = 0.04) and serum creatine kinase activity >100,000 IU/L (OR 0.17; CI 0.04-0.68; P = 0.01) in the univariable analysis as well as recumbency. The latter was the only sign retained in multivariable analysis (OR = 0.19; CI 0.06-0.62; P = 0.006). Administration of vitamins during the disease was associated with survival (OR 3.75; CI 1.21-11.57; P = 0.02). Main limitations: Reporting cases to the Atypical Myopathy Alert Group is voluntary; therefore, under-reporting will result in underestimation of AM cases; furthermore, direct owner-reporting could have introduced misdiagnosis bias. Conclusion: Some areas of the UK reported AM cases more commonly. Clinical signs such as recumbency, rectal temperature, distended bladder and serum creatine kinase activity might be useful prognostic indicators though should be considered in the context of the clinical picture. Treatment with vitamins increases odds of survival.
Introduction
Equine atypical myopathy (AM) is an acute rhabdomyolysis caused by the disruption of mitochondrial fatty acid metabolism in muscle cells following the ingestion of hypoglycin A (HGA) contained in seeds and seedlings of some Acer tree species [1] [2] [3] [4] [5] . The disease has a high mortality rate and there is currently no known specific treatment other than supportive management [6, 7] . Outbreaks of AM vary from year to year and are seasonal, with most cases occurring in the autumn [8] [9] [10] , when seeds are available in pasture and in the subsequent spring, when seedlings are present. In Europe, the main source of HGA seems to be the seeds of Acer pseudoplatanus (sycamore maple) [1] [2] [3] 5] .
Despite AM first been recognised in north east Wales around 1939 [11] , the number of cases reported annually in the UK has been low compared to mainland Europe (Fig 1) . However, a high number of cases were reported during 2014 [12] . The reasons behind the annual fluctuation of cases have not been fully elucidated, but it most likely reflects a combination of factors such as tree maturity [13] , climatological conditions that benefit pollination and thereby influence seed production [14] or those that influence the amount of time that horses spend on pasture during the high risk season. Growing awareness of the disease among equine practitioners and horse owners in recent years, after elucidation of the causative agent, may also influence the reporting of cases.
Overall survival for the disease in a previous European study was 26%, with a maximal survival of 57% noted in France in autumn 2006 [9] . In this same study, factors associated with survival were reported, such as normothermia and remaining standing [15] . The only treatment that showed significant benefits in terms of survival was the administration of vitamins and/or antioxidants [10, 15] . Despite creatine kinase (CK) activity being commonly used to support AM clinical diagnosis, no significant differences have been found between survivors and nonsurvivors [15] .
The purpose of this study was to examine the characteristics of AM in the UK population in recent years focusing on geographical distribution, epidemiological features and factors associated with survival.
Materials and methods

Case selection
Information from AM cases in the UK over a 5-year period (2011-2015) was collected via standardised questionnaires available on the Atypical Myopathy Alert Group website (http://www.myopathieatypique.be) and completed when possible via email or telephone. This website is a surveillance network for cases of AM in Europe, developed by the University of Li ege, Belgium, that gathers information from veterinary surgeons, horse owners, national epidemiological networks and universities. Owner and veterinary questionnaires differed slightly in the detail of information requested regarding management, environment and clinical signs ( Supplementary Items 1 and 2 ). Only cases that followed the AM diagnostic algorithm for confirmed cases or cases with high probability of having AM [9] were included in this study. However, where only ownerreported data were available, more stringent criteria were applied, such that minimum inclusion criteria were horses that had not been strenuously exercised within the previous 48 h, had access to pasture and presented with pigmenturia and/or had serum biochemistry performed.
Data analysis
Statistical analyses were performed using commercial software.
ab Data are described as proportions with 95% confidence intervals (CI) for categorical data and as medians with interquartile ranges (IQR) for continuous data. Kruskal-Wallis and Mann-Whitney U tests were used to test the statistical significance of differences in rank sum values of continuous variables between categories of categorical variables. Pearson Chi-squared or Fisher's exact tests were used to assess associations between categorical variables. Associations between survival after AM diagnosis and case background, management, clinical signs and treatment were assessed using logistic regression analysis. Spearmans's rank correlation coefficients were used to assess correlations between continuous variables prior to model building. Continuous variables were assessed for linearity by conversion to categories and graphical examination of the shape of the relationship with the outcome, with the categorical variable used where the linear assumption was not met. Due to the small proportion of cases for which complete owner-and veterinary-reported data were both obtained, separate multivariable logistic regression models were built for case background and management level (owner and vet-reported) and clinical and treatment level (veterinary-reported) variables, as there were insufficient events per variable for any model that combined management with clinical factors. Variables with P<0.30 in univariable analyses were considered for inclusion in the multivariable logistic regression models, built using a step-wise procedure combining forward selection with subsequent backwards elimination. Variables were excluded from the model if they did not significantly improve its fit based on P>0.05 in likelihood ratio tests. Finally, all excluded variables were individually reintroduced prior to final model selection. Two-way interaction terms between all variables retained in the final models were assessed. The goodness-of-fit of the final models was assessed using the HosmerLemeshow test statistic and the area under the receiver operating characteristic (ROC) curve. The distribution and outlier values of the standardised residuals (difference between the model predicted and actual outcome values) from each model were also assessed. The final models were repeated excluding observations with standardised residual values of <À2.0 or >+2.0. Statistical significance was set at a value of P≤0.05.
Results
A total of 224 cases in the UK occurring between 20 October 2011 and 31 December 2015 were included. Owner-reported data were available for 52.7% of cases (n = 118), veterinary-reported data were available for 35.7% cases (n = 80), and the remaining 11.6% of cases (n = 26) had both ownerand veterinary-reported data. Post-mortem confirmation was only reported in 7.6% of cases (n = 17). Among the vet practices, 83% (n = 93/113) attended one or 2 cases each, 14.3% (16/113) attended 3-6 cases each and 2.7% (n = 3/113) attended 11-16 cases each. The last group only included referral hospitals.
Spatiotemporal distribution of cases
Date of onset of clinical signs was reported for 190 cases, of which the majority occurred during autumn months (73.7%; n = 140; CI 67.4-79.9%), with the greatest proportion of cases reported during October (44.2%; n = 84; CI 37.1-51.3%) and November (28.4%; n = 54; CI 22.0-34.8%; Fig 2) .
The majority of cases occurred in England (87.9%; n = 196/223; CI 83.6-92.2%), with 8.5% of cases reported from Wales (n = 19/223; CI 4.9-12.2%), 2.7% from Scotland (n = 6/223; CI 0.6-4.8%) and 0.9% from Northern Ireland (n = 2/223; CI 0-2.1%). The greatest proportion of cases was reported in southern England, with the counties of Hampshire (13.8%), Wiltshire (7.1%) and Gloucestershire (6.3%; Fig 3) reporting the greatest number of cases.
The majority of affected paddocks were used for equine grazing all year (59.0%; n = 79/134; CI 50.6-67.3%). Sycamore seeds were found in 96.0% (n = 120/125; CI 92.6-99.4%) and sycamore seedlings in 67.6% (n = 50/74; CI 56.9-78.2%) of affected pastures. Most (96%) affected paddocks had trees within/near the pasture (n = 136/142; CI 92.5-99.0%), and of these 16.9% (n = 23/136; CI 10.6-23.2%) noted sycamore trees specifically within/ near the pasture. Grass cover was considered as adequate for 67.4% (n = 95/141; CI 59.6-75.1%) of affected paddocks. One-third of affected paddocks had wet areas and/or natural watercourses within/surrounding them (n = 44/133; CI 25.1-41.1%).
Case signalment and management
The median age of affected horses was 6 years (IQR 2.7-11.6). Males comprised 60.3% of the cases (n = 135/224; CI 53.9-66.8%) and females 39.7% (n = 89/224; CI 33.3-46.1%). Breeds most frequently affected included Cob/Cob crosses (24%; n = 54/224; CI 18.5-29.7%), Thoroughbred/ Thoroughbred crosses (15.2%; n = 34/224; CI 10.5-19.9%), Welsh/Welsh crosses (13.4%; n = 30/224; CI 8.9-17.9%) and other UK native breeds (13.4%; n = 30/224; CI 8.9-17.9%). The majority of horses were reported to be in good body condition (71.1%; n = 64/90; CI 61.7-80.5%) and some were regularly ridden (35.3%; n = 49/139; CI 27.3-43.2%). Only one horse was reported to have had an episode of some form of myopathy previously (0.4%; CI 0-1.3%) and 34.3% horses (n = 74/216; CI 27.9-40.6%) had performed light to moderate exercise within the 48 h period preceding the onset of clinical signs.
The majority of horses had access to pasture (98.6%; n = 210/213; CI 97.0-100%), with most horses reported to be turned out at pasture full time (72.5%; n = 111/153; CI 65.5-79.6%). The median period for which horses had been grazing the affected paddock prior to the onset of clinical signs was 35 days. In addition to grazing, 68.1% of horses had received 
Clinical presentation
The degree of suffering as a result of AM was considered by the owner and/or attending veterinarians to be severe (55.3%; n = 73/132; CI 46.8-63.8%). Dark urine, stiffness and muscle fasciculations were the most prevalent presenting clinical signs (Fig 4) . 
Case outcome
Outcome was reported for 189 cases, of which 38.6% survived (n = 74; CI 32.0-45.9%). Fourteen percent of cases (n = 26; CI 8.8-18.6%) were subjected to euthanasia (n = 23) or died (n = 3) within 24 h of the onset of clinical signs. For nonsurvivors treated for ≥24 h, median time from onset of clinical signs to euthanasia/death was 1 day (IQR 1-3 days).
Univariable logistic regression analysis
Temporal, horse, management and pasture-related factors associated with survival are described in supplementary information (Supplementary Item 5). There was a univariable association between age and survival (P = 0.02), with horses aged >10-15 years having higher odds of survival compared to those aged ≤5 years. A history of being exercised within the 48 h prior to the onset of clinical signs was associated with increase odds of survival (P = 0.03). Amongst nonsurvivors, there was no association between recumbency and euthanasia when compared with natural death (P = 1.0); 86.7% of animals exhibiting recumbency (n = 39/45; CI 76.7-96.6%) were subjected to euthanasia compared to 87.5% of those not reported to have been recumbent (n = 28/32; CI 76.0-99.0%).
Clinical presentation and treatment-related factors associated with survival are described in Supplementary Item 6.
Multivariable logistic regression analysis
Data from 82 cases (36 survivors; 46 nonsurvivors) were included in the case background and management level multivariable logistic regression model (Table 1) . Compared to England, cases of AM occurring in Wales or Northern Ireland had increased odds of survival. Horses that had access to a salt block had increased odds of survival compared to those that did not. Similarly, horses supplemented with vitamins/minerals had increased odds of survival compared to those not receiving supplementation; although for this association it is noted that the lower boundary of the 95% confidence interval around the effect size point estimate was below 1.0. Compared to horses turned out in paddocks that were used seasonally, horses grazing paddocks that were used all year had decreased odds of survival. No significant interaction terms were identified. The Hosmer-Lemeshow statistic for the final model was 5.40 (P = 0.5) and the area under the ROC curve was 0.83 (CI 0.73-0.92). Removal of 4 outlying individual observations with the largest standardised residual values outside the range À2.0 to +2.0 had little effect on coefficients; therefore, all observations were retained in the model (Table 1) .
Due to the resultant reduction in number of available subjects' clinical variables for which data were available for <50 cases were not considered for inclusion in this multivariable model. Data from 71 cases (23 survivors; 48 nonsurvivors) were included in the most robust final logistic regression model of clinical presentation and treatment level variables. Horses reported to have become recumbent had decreased odds of survival while those that were treated with vitamin preparations as part of veterinary treatment for AM had increased odds of survival. The Hosmer-Lemeshow statistic for the final model was 1.50 (P = 0.5) and the area under the ROC curve was 0.75 (CI 0.64-0.87). Removal of the single outlying observation with the largest standardised residual value had little effect on coefficients; therefore, all observations were retained in the model.
Discussion
This is the first epidemiological study of AM that focuses on the UK. It supports previous findings in Europe [9, 15] and North America [4, 16] , but it also highlights management and treatment strategies that will need consideration for further research and identifies areas of the country that reported cases more frequently. The main limitation of the study was the extent of missing data and the voluntary reporting of cases. Phone calls and/or email communication was attempted in order to complete the data set for those participants who gave permission for further contact; however, the compliance of participants remained low. As a result, construction of the multivariable models was challenging and determined the number of cases with suitable data for multivariable model analysis. This is the first study to include a large data set of owner-reported disease and therefore misclassification of cases was possible although should have been minimised with the strict inclusion criteria applied. Sycamore trees have been implicated in the disease as a source of HGA [1] [2] [3] 5] . In this study, 96% of respondents were aware of sycamore seeds within the affected pasture and a further 64% noticed the presence of sycamore seedlings. These data further support the implication of sycamore trees in the disease with a greater number of premises at a national level, putting together sources of HGA and affected horses. Geographical distribution of cases clustered in some English counties, although it was not possible to establish a link between AM cases and density of A. pseudoplatanus trees in those areas as current botanical surveys only refer to presence of trees [17] . Distribution of cases might alternatively reflect the location and/or population density of equids in some areas of the UK; however, without an accurate equine census [18] this potential factor remains speculative.
Overall survival was higher than reported in previous studies [9, 19] . Increased awareness among equine practitioners and horse owners in recent years might have expedited early recognition and treatment of the condition, and as identified by this study, animals that received veterinary treatment were more likely to survive. This latter association might be linked to a veterinarian's clinical judgement, as those animals with severe clinical signs at presentation could have been subjected to euthanasia without treatment attempted.
Consistent with a previous study of European cases, the vast majority of horses in the current study had access to grazing for at least 6 h a day (97%; Supplementary Item 5). In addition, this work showed that the median time that horses had grazed the affected pasture was 35 days prior to the onset of clinical signs. It is possible that progressive and/or continuous intake of HGA over a period is required for toxicity through its conversion to methylenecyclopropyl acetic acid (MCPA). Variability in maximum HGA tolerated dose in horses and potential cumulative effects might also have influenced our results, but data supporting these factors are currently lacking. The use of pastures all year around was associated with decreased odds of survival on multivariable analysis; permanent use of the same grazing land could have increased the exposure to sycamore seeds through reduced grass length as well as by dominance behaviours among cograzers. The use of supplementary feeding was not associated with survival in contrast to previous observations; however, previous studies compared affected vs. unaffected horses [10, 20] .
The biochemical phenotype of AM has been compared with multiple acyl-CoA dehydrogenase deficiency (MADD) in man [21, 22] . Exercise capacity impairment is linked to inherited MADD [23, 24] and some of those myopathic forms are triggered by exercise, fasting or extreme temperatures [23] . Conversely, in healthy individuals, moderate exercise increases average oxygen uptake, cardiac output and mitochondrial enzyme expression, some of the earliest muscle adaptations to exercise [25, 26] . In the current study, exercise prior to the onset of disease increased odds of survival on univariable analysis; although this did not remain significant in the much reduced final multivariable logistic regression model, it will be worthy of further study in the future. The low proportion of respondents providing information regarding regular exercise makes it difficult to differentiate animals that were undertaking regular exercise from those that had occasional exercise prior to AM. Training was also suggested as a protective factor previously [10] . It is possible that the animals that had been recently exercised might have a greater oxidative capacity and therefore were less prone to absolute MCPA-dehydrogenase inhibition. In addition, horses that undertake regular activity are handled almost daily and therefore the likelihood of detecting some medical problems at an early stage is probably higher.
A marginal but positive association between survival and routine vitamin and mineral supplementation (owner administered), including salt blocks/licks was found in this study and warrants further research. Moderate riboflavin deficiency exacerbated the negative outcome of MADD in rodent models [27, 28] . There is contradictory information about riboflavin plasma concentration in AM horses: one study did not find differences when compared with controls [22] but a recent study showed that it was significantly reduced in serum of AM horses [29] . The lack of information regarding vitamin types contained in the supplements administered to affected horses precludes assessment of the effect of oral riboflavin administration (or that of any other specific vitamin) in this study.
A previous study reported positive association between survival and administration of vitamin treatments that included carnitine [15] . In this study, carnitine treatment was reported as a separate category, and therefore it was feasible to split the specific treatments to explore the potential effect; however, only 2 horses received it. Carnitine does not seem to have pronounced effects on either the impairment of acyl-CoA or the alterations on CoA profiles that were associated with MCPA-induced MADD [30, 31] . No studies have confirmed a benefit of isolated use of carnitine in patients with primary mitochondrial disorders. Besides, carnitine concentration was increased in blood of affected horses [32] . Although there is no objective evidence of its beneficial effect, carnitine might facilitate the removal of accumulating toxic acyl intermediates and the generation of mitochondrial CoA [33, 34] , supporting normal muscular function during convalescence. Veterinary administered vitamin preparations were also significantly associated with increased odds of survival in this study. The use of riboflavin to ameliorate MCPA cellular effects has been documented in several studies [31, 35] , this vitamin seems to allow the synthesis of new acyl-CoA dehydrogenases that have flavin prosthetic groups [36, 37] and suggests a promising treatment option for AM. Despite the lack of significance in the multivariable analysis, some prognostic factors identified in the univariable analysis can be considered of clinical relevance. Hypothermia, elevated heart rate and distended bladder have been recognised as clinical signs frequently encountered in horses with AM [8, 15] but it has not been previously shown to be associated with survival. Low body temperature is most likely a consequence of systemic shock while bladder distention could be linked to partial disruption and/or paresis of bladder muscles. In addition, CK serum activity was negatively associated with survival in this study, in contrast to previous studies [8, 15] . This association may have relevance for practitioners as most have access to biochemistry analysers and results can be available soon after examination. Nevertheless, the lack of significance in the multivariable analysis warrants caution in the interpretation of this finding; indeed, any decision for euthanasia should be based on the clinical examination and context, not solely on serum biochemistry results. Middle-aged horses were more likely to survive AM when compare with horses younger than 5 years, as reported in previous studies [10, 20] . It is unknown whether there could be an age-specific sensitivity for the toxin, or it is related to diet or management habits of this age group.
Recumbency was strongly associated with decreased odds of survival as previously reported [15] . This presentation probably reflects the severity of generalised paresis exhibited by an affected horse given the difficulty in managing such cases for extended periods. The poor survival of recumbent horses might also reflect a bias for euthanasia decision from owner, veterinary surgeon or both.
Conclusion
This study describes the temporal and geographical distribution of AM in the UK between 2011 and 2015. Clinical findings such as recumbency, hypothermia, distended bladder on rectal examination and markedly raised serum CK activity were identified as potentially useful prognostic indicators. Treatment with vitamin preparations during the course of disease improved the odds of survival in affected horses. Further research is necessary to unravel the value of specific vitamins as therapeutic options for AM.
